{
    "Individual": {
        "Species": "Human",
        "Population": "European_ICRP_2002",
        "Gender": "MALE",
        "Age": 30,
        "Weight": 80,
        "Height": 17.8,
        "Enzymes": [{
            "Name": "CYP3A4",
            "ReferenceConcentration": 4.32,
            "HalfLifeLiver": 2220,
            "HalfLifeIntestine": 960,
            "Expressions": {
                "Pericentral": 1,
                "Periportal": 1
            }
        }]
    },
    "Compounds": [
        {
            "Name": "drug",
            "Lipophilicity": 3,
            "FractionUnbound": 0.8,
            "MolWeight": 4.0E-7,
            "SolubilityAtRefpH": 1.0E-7,
            "RefpH": 9,
            "PkaTypes": [{
                "Type": "Acid",
                "Value": 8
            }],
            "PartialProcesses": [{
                "MoleculeName": "CYP3A4",
                "InternalName": "MetabolizationSpecific_MM",
                "DataSource": "Lab",
                "ParameterValues": {"Vmax": 10}
            }],
            "CalculationMethods": ["Cellular partition coefficient method - Rodgers and Rowland"]
        },
        {
            "Name": "inhibitor",
            "Lipophilicity": 2,
            "FractionUnbound": 0.6,
            "MolWeight": 3.0E-7,
            "SolubilityAtRefpH": 1.0E-7,
            "RefpH": 9,
            "PkaTypes": [{
                "Type": "Acid",
                "Value": 8
            }],
             "PartialProcesses": [{
                "MoleculeName": "CYP3A4",
                "InternalName": "IrreversibleInhibition",
                "DataSource": "Lab",
                "ParameterValues": {"kinact": 1, "K_kinact_half": 0.5}
            }],
            "CalculationMethods": ["Cellular partition coefficient method - Rodgers and Rowland"]
        }
    ],
    "ApplicationProtocols": [
        {
            "Name": "iv1",
            "CompoundName": "drug",
            "DosingInterval": "DI_12_12",
            "ApplicationType": "IntravenousBolus",
            "Dose": 2,
            "DoseUnit": "mg",
            "EndTime": 1440
        },
        {
            "Name": "iv2",
            "CompoundName": "inhibitor",
            "DosingInterval": "DI_6_6_6_6",
            "ApplicationType": "IntravenousBolus",
            "Dose": 5,
            "DoseUnit": "mg",
            "EndTime": 1440
        }
    ],
    "Interactions": [{
        "ProcessName": "CYP3A4-Lab",
        "MoleculeName": "CYP3A4",
        "CompoundName": "inhibitor"
    }],
    "Configuration": {"Model": "4Comp"}
}